| __timestamp | Jazz Pharmaceuticals plc | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 85181000 | 242549000 |
| Thursday, January 1, 2015 | 135253000 | 245098000 |
| Friday, January 1, 2016 | 162297000 | 147600000 |
| Sunday, January 1, 2017 | 198442000 | 264600000 |
| Monday, January 1, 2018 | 226616000 | 357900000 |
| Tuesday, January 1, 2019 | 299726000 | 1182600000 |
| Wednesday, January 1, 2020 | 335375000 | 357700000 |
| Friday, January 1, 2021 | 505748000 | 540100000 |
| Saturday, January 1, 2022 | 590453000 | 322900000 |
| Sunday, January 1, 2023 | 849658000 | 408000000 |
Unveiling the hidden dimensions of data
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, United Therapeutics Corporation and Jazz Pharmaceuticals plc have demonstrated distinct strategies in their R&D investments. From 2014 to 2023, United Therapeutics consistently allocated a significant portion of its budget to R&D, peaking in 2019 with a remarkable 1.18 billion dollars. This represents a 388% increase from its 2014 spending. Meanwhile, Jazz Pharmaceuticals showed a steady upward trend, culminating in 2023 with an 849 million dollar investment, a tenfold increase from 2014. This strategic allocation underscores the companies' commitment to pioneering new treatments and maintaining a competitive edge. As the biopharma landscape evolves, these investments will likely play a crucial role in shaping the future of healthcare.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.